UniProt Q6V1X1
Dipeptidyl peptidase 8 (Q6V1X1)
Dipeptidyl peptidase 8 (UniProt Q6V1X1), EC 3.4.14.5: 36 experimental structures and 1 predicted model on GenesisL1, 20 ligands bound, 371 pockets. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.
- UniProt
- Q6V1X1
- Protein
- Dipeptidyl peptidase 8
- EC
- 3.4.14.5
- Experimental structures
- 36
- Predicted models
- 1
- Ligands
- 20
- Pockets
- 371 · 19 records with a druggable one
Structures
37 records of Q6V1X1 in the MolNFT archive: 36 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 6EOO | DPP8 - Apo, space group 20 | x-ray diffraction | A, B, C | — | 20 (best 0.81) |
| 6EOO | DPP8 - apo, space group 20 | x-ray diffraction | A, B, C | — | — |
| 6EOP | DPP8 - SLRFLYEG, space group 20 | x-ray diffraction | A, B, C | CA, F15 | 20 (best 0.86) |
| 6EOP | DPP8 - slrflyeg, space group 20 | x-ray diffraction | A, B, C | CA, F15 | — |
| 6EOS | DPP8 - Apo, space group 19 | x-ray diffraction | A, C, D, E, F, B | — | 20 (best 0.81) |
| 6EOS | DPP8 - apo, space group 19 | x-ray diffraction | A, C, D, E, F, B | — | — |
| 6EOT | DPP8 - SLRFLYEG, space group 19 | x-ray diffraction | A, B, D, G, I, K | — | 20 (best 0.85) |
| 6EOT | DPP8 - slrflyeg, space group 19 | x-ray diffraction | A, B, D, G, I, K | — | — |
| 6HP8 | Crystal structure of DPP8 in complex with Val-BoroPro | x-ray diffraction | A, B, C | GK2, NA | 20 (best 0.82) |
| 6HP8 | Crystal structure of DPP8 in complex with val-boropro | x-ray diffraction | A, B, C | GK2, NA | — |
| 6QZW | DPP8 bound to a dipeptide (MP) from the N-terminus of BRCA2 | x-ray diffraction | C, A, B | NA | 20 (best 0.81) |
| 6QZW | DPP8 bound to a dipeptide (mp) from the N-terminus of BRCA2 | x-ray diffraction | C, A, B | NA | — |
| 6TRW | Crystal structure of DPP8 in complex with the EIL peptide (SLRFLFEGQRIADNH) | x-ray diffraction | A, B, C | NA | 20 (best 0.85) |
| 6TRW | Crystal structure of DPP8 in complex with the eil peptide (slrflfegqriadnh) | x-ray diffraction | A, B, C | NA | — |
| 6TRX | Crystal structure of DPP8 in complex with 1G244 | x-ray diffraction | B, A, C | TMO, 9XH, NA, PO4 | 20 (best 0.83) |
| 6TRX | Crystal structure of DPP8 in complex with 1G244 | x-ray diffraction | B, A, C | TMO, 9XH, NA, PO4 | — |
| 7A3G | Crystal structure of DPP8 in complex with a 4-oxo-b-lactam based inhibitor, 91 | x-ray diffraction | B, A | TMO, QXQ, PO4, QXT, CL | 19 (best 0.80) |
| 7A3G | Crystal structure of DPP8 in complex with a 4-oxo-B-lactam based inhibitor, 91 | x-ray diffraction | B, A | TMO, QXQ, PO4, QXT, CL | — |
| 7A3I | Crystal structure of DPP8 in complex with a 4-oxo-b-lactam based inhibitor, LMC375 | x-ray diffraction | A, B, C | TMO, QXH, NA, CL | 20 (best 0.79) |
| 7A3I | Crystal structure of DPP8 in complex with a 4-oxo-B-lactam based inhibitor, LMC375 | x-ray diffraction | A, B, C | TMO, QXH, NA, CL | — |
| 7A3J | Crystal structure of DPP8 in complex with a 4-oxo-b-lactam based inhibitor, A272 | x-ray diffraction | C, A, B | QXK, TMO, CL | 20 (best 0.83) |
| 7A3J | Crystal structure of DPP8 in complex with a 4-oxo-B-lactam based inhibitor, A272 | x-ray diffraction | C, A, B | QXK, TMO, CL | — |
| 7A3K | Crystal structure of DPP8 in complex with a b-lactam based inhibitor, A296.1 | x-ray diffraction | C, A, B | TMO, CL, NA, QX8 | 20 (best 0.83) |
| 7A3K | Crystal structure of DPP8 in complex with a B-lactam based inhibitor, A296.1 | x-ray diffraction | C, A, B | TMO, CL, NA, QX8 | — |
| 7A3L | Crystal structure of DPP8 in complex with a 4-oxo-b-lactam based inhibitor, A241 | x-ray diffraction | A, B, C | QXN, TMO, CL | 20 (best 0.83) |
| 7A3L | Crystal structure of DPP8 in complex with a 4-oxo-B-lactam based inhibitor, A241 | x-ray diffraction | A, B, C | QXN, TMO, CL | — |
| 7AYQ | Crystal structure of DPP8 in complex with a 4-oxo-b-lactam based inhibitor, B114 | x-ray diffraction | A, B | TMO, PO4, S9Z | 20 (best 0.79) |
| 7AYQ | Crystal structure of DPP8 in complex with a 4-oxo-B-lactam based inhibitor, B114 | x-ray diffraction | A, B | TMO, PO4, S9Z | — |
| 7AYR | Crystal structure of DPP8 in complex with a 4-oxo-b-lactam based inhibitor, B115 | x-ray diffraction | A, B | TMO, PO4, S9W | 19 (best 0.79) |
| 7AYR | Crystal structure of DPP8 in complex with a 4-oxo-B-lactam based inhibitor, B115 | x-ray diffraction | A, B | TMO, PO4, S9W | — |
| 7OR4 | Crystal structure of DPP8 in complex with a 4-oxo-b-lactam based inhibitor, B142 | x-ray diffraction | B, A | TMO, 2YI | 16 (best 0.77) |
| 7OR4 | Crystal structure of DPP8 in complex with a 4-oxo-B-lactam based inhibitor, B142 | x-ray diffraction | B, A | TMO, 2YI | — |
| 7OZ7 | Crystal structure of DPP8 in complex with a 4-oxo-b-lactam based inhibitor, L84 | x-ray diffraction | A, B | MQ2, TMO | 17 (best 0.78) |
| 7OZ7 | Crystal structure of DPP8 in complex with a 4-oxo-B-lactam based inhibitor, L84 | x-ray diffraction | A, B | MQ2, TMO | — |
| 7SVM | DPP8 IN COMPLEX WITH LIGAND ICeD-2 | x-ray diffraction | A, B, C | D06, TMO | 20 (best 0.81) |
| 7SVO | DPP8 IN COMPLEX WITH LIGAND ICeD-1 | x-ray diffraction | A, B, C | CW8, TMO | 20 (best 0.81) |
| Q6V1X1 | AlphaFold monomer V2.0 prediction for dipeptidyl peptidase 8 (Q6V1X1) | predicted | A | — | — |
Ligands
- TMO · trimethylamine oxide · in 22 records
- NA · Sodium ion · in 12 records
- CL · Chloride ion · in 10 records
- PO4 · Phosphate ion · in 8 records
- 2YI · Methyl 3-[4-[(4-bromophenyl)methyl]piperazin-1-yl]carbonyl-5-[(2-ethyl-2-methanoyl-butanoyl) amino]benzoate · in 2 records
- 9XH · (2~{S})-2-azanyl-4-[4-[bis(4-fluorophenyl) methyl]piperazin-1-yl]-1-(1,3-dihydroisoindol-2-yl) butane-1,4-dione · in 2 records
- CA · Calcium ion · in 2 records
- F15 · Pentadecanoic acid · in 2 records
- GK2 · [(2~{R})-1-[(2~{R})-2-azanyl-3-methyl-butanoyl]pyrrolidin-2-yl]boronic acid · in 2 records
- MQ2 · ~{N}-[3-[[4-[(4-bromophenyl)methyl]piperazin-1-yl]methyl]phenyl]-2-ethyl-2-methanoyl-butanamide · in 2 records
- QX8 · 1-[3-[[4-[(4-bromophenyl)methyl]piperazin-1-yl]methyl]phenyl]azetidin-2-one · in 2 records
- QXH · ~{N}-[3,5-bis[[4-[(4-bromophenyl)methyl]piperazin-1-yl]methyl]phenyl]-2-ethyl-2-methanoyl-butanamide · in 2 records
- QXK · 2-ethyl-2-methanoyl-~{N}-[3-[[4-(naphthalen-1-ylmethyl)piperazin-1-yl]methyl]phenyl]butanamide · in 2 records
- QXN · 2-ethyl-2-methanoyl-~{N}-[3-[(4-methylpiperazin-1-yl) methyl]phenyl]butanamide · in 2 records
- QXQ · ~{N}-[3-(7,8-dihydro-5~{H}-[1,3]dioxolo[4,5-g]isoquinolin-6-ylmethyl)phenyl]-2-ethyl-2-methanoyl-butanamide · in 2 records
- QXT · 1-[3-(7,8-dihydro-5~{H}-[1,3]dioxolo[4,5-g]isoquinolin-6-ylmethyl)phenyl]-3,3-diethyl-azetidine-2,4-dione · in 2 records
- S9W · ~{N}-[3-[[4-[(4-bromophenyl)methyl]piperazin-1-yl]methyl]phenyl]-4-methanoyl-oxane-4-carboxamide · in 2 records
- S9Z · ~{N}-[3-[4-[(4-bromophenyl)methyl]piperazin-1-yl]carbonylphenyl]-2-ethyl-2-methanoyl-butanamide · in 2 records
- CW8 · (2S,4S)-1-[(2S)-2-amino-2-cyclohexylacetyl]-4-fluoropyrrolidine-2-carbonitrile · in 1 record
- D06 · (2S)-2-amino-1-(1,3-dihydro-2H-isoindol-2-yl)-2-[(1r,4S)-4-(pyrrolidin-1-yl)cyclohexyl]ethan-1-one · in 1 record
Experiment against prediction
- 6EOP chain B against the predicted model Q6V1X1: TM-score 1.00, RMSD 0.68 Å
- 6EOP chain B against the predicted model Q6V1X1: TM-score 1.00, RMSD 0.68 Å
- 6TRW chain B against the predicted model Q6V1X1: TM-score 1.00, RMSD 0.69 Å
- 6TRW chain B against the predicted model Q6V1X1: TM-score 1.00, RMSD 0.69 Å
- 6QZW chain A against the predicted model Q6V1X1: TM-score 1.00, RMSD 0.70 Å
- 6QZW chain A against the predicted model Q6V1X1: TM-score 1.00, RMSD 0.70 Å
- 6TRX chain B against the predicted model Q6V1X1: TM-score 0.99, RMSD 0.72 Å
- 6TRX chain B against the predicted model Q6V1X1: TM-score 0.99, RMSD 0.72 Å
- 6EOP chain C against the predicted model Q6V1X1: TM-score 0.99, RMSD 0.73 Å
- 6EOP chain C against the predicted model Q6V1X1: TM-score 0.99, RMSD 0.73 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.